Q1 EPS Estimates for Globus Medical Reduced by Roth Capital
Globus Medical, Inc. (NYSE:GMED – Free Report) – Analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and investors on Friday, February 21st. Roth Capital analyst J. Wittes now expects that the medical device company will earn $0.74 per share for the quarter, down […]
